STADA: CapVest Completes Majority Acquisition Of Global Pharmaceuticals Company - Pulse 2.0
CapVest→STADA Arzneimittel
Apr 1, 2026
ClearPoint Neuro has completed the acquisition of IRRAS Holdings, a medical devices business in California, for an undisclosed amount. IRRAS Holdings develops and commercializes neurostimulation and related medical device technologies used in healthcare settings, supporting ClearPoint Neuro’s expansion in CA acquisitions. ClearPoint Neuro acquisitions add IRRAS’s product capabilities to strengthen its healthcare M&A strategy and broaden its merger acquisition portfolio. The closed strategic acquisition is structured as a merger acquisition, with ClearPoint Neuro acting as a strategic buyer pursuing a strategic acquisition of a complementary medical devices platform.
CapVest→STADA Arzneimittel
Apr 1, 2026
Lilly→Centessa Pharmaceuticals
Mar 31, 2026
Jimini Health
Mar 31, 2026
Eris Lifesciences→Velbiom Probiotics
Mar 31, 2026
Biogen→Apellis Pharmaceuticals
Mar 31, 2026